Skip to content

Drug interactions

Doxycycline + Repotrectinib

Severity: Minor

Doxycycline and Repotrectinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Repotrectinib is metabolized by CYP3A4, so inhibitors can raise exposure and CNS effects such as dizziness and ataxia. Doxycycline is not an established CYP3A4 inhibitor, so a clinically significant effect is unlikely.

What this interaction means in plain words

Doxycycline and Repotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Doxycycline belongs to Anti Bacterial; Repotrectinib belongs to Oncology.

Evidence level: Low

Why it happens

Theoretical weak CYP3A4 inhibition by doxycycline.

What to do

No dose change needed; monitor for dizziness, ataxia and other neurologic adverse effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Doxycycline and Repotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Doxycycline with Repotrectinib?

MediHelp rates the interaction as minor. Doxycycline and Repotrectinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Repotrectinib is metabolized by CYP3A4, so inhibitors can raise exposure and CNS effects such as dizziness and ataxia. Doxycycline is not an established CYP3A4 inhibitor, so a clinically significant effect is unlikely.

How serious is the interaction between Doxycycline and Repotrectinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change needed; monitor for dizziness, ataxia and other neurologic adverse effects.

What other medicines interact with Doxycycline?

MediHelp also lists interactions of Doxycycline with, for example, Acitretin, Aminolevulinic acid, Cholera vaccine. The full list is on the Doxycycline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in